Investigation of the Feasibility of Ventricular Delivery of Resveratrol to the Microelectrode Tissue Interface

• Published in: Micromachines (Basel) Vol. 12; no. 12; p. 1446
• Main Authors: Kim, Youjoung, Ereifej, Evon S, Schwartzman, William E, Meade, Seth M, Chen, Keying, Rayyan, Jacob, Feng, He, Aluri, Varoon, Mueller, Natalie N, Bhambra, Raman, Bhambra, Sahaj, Taylor, Dawn M, Capadona, Jeffrey R
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 25.11.2021; MDPI
• Subjects: antioxidant; Antioxidants; Bioavailability; Biomarkers; Brain; Cannulae; Catheters; Chemokines; Cytokines; Electrodes; Elution; Enzymes; Foreign bodies; foreign body response; Inspection; intracortical microelectrode; Metabolism; Microelectrodes; neural; neural recording; Optimization; Oxidative stress; ventricular drug delivery; United States > US; antioxidant; foreign body response; intracortical microelectrode; neural; neural recording; ventricular drug delivery
• ISSN: 2072-666X; 2072-666X
• DOI: 10.3390/mi12121446

(1) Background: Intracortical microelectrodes (IMEs) are essential to basic brain research and clinical brain-machine interfacing applications. However, the foreign body response to IMEs results in chronic inflammation and an increase in levels of reactive oxygen and nitrogen species (ROS/RNS). The current study builds on our previous work, by testing a new delivery method of a promising antioxidant as a means of extending intracortical microelectrodes performance. While resveratrol has shown efficacy in improving tissue response, chronic delivery has proven difficult because of its low solubility in water and low bioavailability due to extensive first pass metabolism. (2) Methods: Investigation of an intraventricular delivery of resveratrol in rats was performed herein to circumvent bioavailability hurdles of resveratrol delivery to the brain. (3) Results: Intraventricular delivery of resveratrol in rats delivered resveratrol to the electrode interface. However, intraventricular delivery did not have a significant impact on electrophysiological recordings over the six-week study. Histological findings indicated that rats receiving intraventricular delivery of resveratrol had a decrease of oxidative stress, yet other biomarkers of inflammation were found to be not significantly different from control groups. However, investigation of the bioavailability of resveratrol indicated a decrease in resveratrol accumulation in the brain with time coupled with inconsistent drug elution from the cannulas. Further inspection showed that there may be tissue or cellular debris clogging the cannulas, resulting in variable elution, which may have impacted the results of the study. (4) Conclusions: These results indicate that the intraventricular delivery approach described herein needs further optimization, or may not be well suited for this application.